Analysis of gene variation and long-term follow-up in children with phenylalanine hydroxylase deficiency diagnosed by newborn screening.
10.3724/zdxbyxb-2023-0450
- Author:
Meng SUN
1
;
Yulin LI
2
;
Panpan LI
2
;
Gaijie LI
2
;
Yan YAN
2
;
Hui ZOU
3
Author Information
1. Newborn Disease Screening Center, Jinan Maternal and Child Care Hospital, Jinan 250001, China. sun5331@163.com.
2. Newborn Disease Screening Center, Jinan Maternal and Child Care Hospital, Jinan 250001, China.
3. Newborn Disease Screening Center, Jinan Maternal and Child Care Hospital, Jinan 250001, China. zouhui819@163.com.
- Publication Type:Journal Article
- Keywords:
Follow-up studies;
Gene;
Newborn screening;
Phenylalanine hydroxylase deficiency;
Prognosis
- MeSH:
Child;
Child, Preschool;
Adolescent;
Humans;
Infant, Newborn;
Young Adult;
Adult;
Neonatal Screening;
Follow-Up Studies;
Retrospective Studies;
Phenylketonurias/genetics*;
Phenylalanine Hydroxylase/genetics*;
Phenylalanine/therapeutic use*;
Mutation
- From:
Journal of Zhejiang University. Medical sciences
2023;52(6):701-706
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:To retrospectively analyze the variation and characteristics of phenylalanine hydroxylase (PAH) gene, and to observe the long-term treatment effect and follow-up of newborns with PAH deficiency.
METHODS:Clinical data, treatment and follow-up results of 198 patients with PAH deficiency diagnosed by newborn screening in Jinan from 1996 to 2021 were collected. The genetic analysis of 55 patients with PAH deficiency diagnosed by newborn screening in Jinan and 213 patients referred from the surrounding areas of Jinan were summarized. Gene variations were checked by a customized Panel gene detection method. Blood phenylalanine-concentration and physical development indicators including height and weight were regularly monitored. Intellectual development was assessed using a neuropsychological development scale for patients aged 0-6 years and academic performance, and brain injury in patients was assessed using brain magnetic resonance imaging.
RESULTS:c.728G>A, c.158G>A, c.721C>T, c.1068C>A, c.611A>G variations were common in PAH gene. The genotype of c.158G>A variation is compound heterozygous variation, with mainly a mild hyperpheny-lalaninemia. 168 patients with PAH deficiency who were followed-up regularly had normal physical development without dwarfism or malnutrition. Among the 33 preschool patients who underwent mental development assessment, 2 were mentally retarded and the initial treatment age was older than 6 months. Nine patients with an average age of (17.13±2.42) years completed brain magnetic resonance imaging, one case was normal, and 8 cases were abnormal. There were patchy or patchy hyperintense foci near the bilateral lateral ventricles on T2WI, and the intellectual development was normal. Compared with the other eight patients, the blood phenylalanine concentration of the normal child was better and stably controlled within the ideal range.
CONCLUSIONS:c.728G>A, c.158G>A, c.721C>T, c.1068C>A, c.611A>G variations were common in PAH gene. After standardized treatment, most patients with PAH deficiency diagnosed by screening can obtain normal growth and intellectual development in adolescence, but there are different degrees of organic lesions in the cerebral white matter.
